Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma
Conditions:   Clinical Stage I Gastric Cancer AJCC v8;   Clinical Stage IIA Gastric Cancer AJCC v8;   Clinical Stage III Gastric Cancer AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Gastric Adenocarcinoma;   Pathologic Stage IB Gastric Cancer AJCC v8;   Pathologic Stage II Gastric Cancer AJCC v8;   Pathologic Stage IIA Gastric Cancer AJCC v8;   Pathologic Stage IIB Gastric Cancer AJCC v8;   Pathologic Stage III Gastric Cancer AJCC v8;   Pathologic Stage IIIA Gastric Cancer AJCC v8;   Pathologic Stage IIIB Gastric Cancer AJCC v8;   Pathologic Stage IIIC Gastric Cancer AJCC v8;   Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8;   Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8;   Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8
Interventions:   Drug: Capecitabine;   Drug: Fluorouracil;   Radiation: Radiation Therapy;   Procedure: Therapeutic Surgical Procedure
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 25, 2020 / by / in
Comments